In acute myeloid leukemia (AML), a disease characterized by broad genetic and morphological heterogeneity, a general increase in HIF1α and HIF2α protein levels was reported in mouse and human AML cells when compared to normal BM leukocytes (70). Here, HIF1A is linked to acute myeloid leukemia.